158 related articles for article (PubMed ID: 9321761)
41. A genetic register for von Hippel-Lindau disease.
Maddock IR; Moran A; Maher ER; Teare MD; Norman A; Payne SJ; Whitehouse R; Dodd C; Lavin M; Hartley N; Super M; Evans DG
J Med Genet; 1996 Feb; 33(2):120-7. PubMed ID: 8929948
[TBL] [Abstract][Full Text] [Related]
42. Genetic counseling can influence the course of a suspected familial cancer syndrome patient: from a case of Li-Fraumeni like syndrome with a germline mutation in the TP53 gene.
Hwang SM; Lee ES; Shin SH; Kong SY
Korean J Lab Med; 2008 Dec; 28(6):493-7. PubMed ID: 19127115
[TBL] [Abstract][Full Text] [Related]
43. Pancreatic cancer screening in high-risk individuals with germline genetic mutations.
DaVee T; Coronel E; Papafragkakis C; Thaiudom S; Lanke G; Chakinala RC; Nogueras González GM; Bhutani MS; Ross WA; Weston BR; Lee JH
Gastrointest Endosc; 2018 Jun; 87(6):1443-1450. PubMed ID: 29309780
[TBL] [Abstract][Full Text] [Related]
44. Third international workshop on collaborative interdisciplinary studies of p53 and other predisposing genes in Li-Fraumeni syndrome.
Eng C; Schneider K; Fraumeni JF; Li FP
Cancer Epidemiol Biomarkers Prev; 1997 May; 6(5):379-83. PubMed ID: 9149899
[No Abstract] [Full Text] [Related]
45. ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes.
Syngal S; Brand RE; Church JM; Giardiello FM; Hampel HL; Burt RW;
Am J Gastroenterol; 2015 Feb; 110(2):223-62; quiz 263. PubMed ID: 25645574
[TBL] [Abstract][Full Text] [Related]
46. High frequency of de novo mutations in Li-Fraumeni syndrome.
Gonzalez KD; Buzin CH; Noltner KA; Gu D; Li W; Malkin D; Sommer SS
J Med Genet; 2009 Oct; 46(10):689-93. PubMed ID: 19556618
[TBL] [Abstract][Full Text] [Related]
47. Current status of clinical care for familial endocrine tumor syndromes in Japan.
Sakurai A; Uchino S; Takami H
Endocr J; 2005 Dec; 52(6):757-62. PubMed ID: 16410669
[TBL] [Abstract][Full Text] [Related]
48. Early detection of adrenocortical carcinoma in a child with Li-Fraumeni syndrome.
Lin MT; Shieh JJ; Chang JH; Chang SW; Chen TC; Hsu WH
Pediatr Blood Cancer; 2009 Apr; 52(4):541-4. PubMed ID: 19101993
[TBL] [Abstract][Full Text] [Related]
49. Tumors of central and peripheral nervous system associated with inherited genetic syndromes.
Stefanaki K; Alexiou GA; Stefanaki C; Prodromou N
Pediatr Neurosurg; 2012; 48(5):271-85. PubMed ID: 23796843
[TBL] [Abstract][Full Text] [Related]
50. Economic evaluation of the familial cancer programme in Western Australia: predictive genetic testing for familial adenomatous polyposis and hereditary non-polyposis colorectal carcinoma.
Breheny N; Geelhoed E; Goldblatt J; Ee H; O'Leary P
Community Genet; 2006; 9(2):98-106. PubMed ID: 16612060
[TBL] [Abstract][Full Text] [Related]
51. [Hereditary cancer and genetic testing: the role of division of clinical and molecular genetics].
Fukushima Y
Nihon Rinsho; 2000 Jun; 58(6):1262-6. PubMed ID: 10879051
[TBL] [Abstract][Full Text] [Related]
52. Recent developments in brain tumor predisposing syndromes.
Johansson G; Andersson U; Melin B
Acta Oncol; 2016; 55(4):401-11. PubMed ID: 26634384
[TBL] [Abstract][Full Text] [Related]
53. Hereditary colorectal cancer syndromes: American Society of Clinical Oncology Clinical Practice Guideline endorsement of the familial risk-colorectal cancer: European Society for Medical Oncology Clinical Practice Guidelines.
Stoffel EM; Mangu PB; Gruber SB; Hamilton SR; Kalady MF; Lau MW; Lu KH; Roach N; Limburg PJ; ;
J Clin Oncol; 2015 Jan; 33(2):209-17. PubMed ID: 25452455
[TBL] [Abstract][Full Text] [Related]
54. Von Hippel-Lindau Disease: Genetics and Role of Genetic Counseling in a Multiple Neoplasia Syndrome.
Nielsen SM; Rhodes L; Blanco I; Chung WK; Eng C; Maher ER; Richard S; Giles RH
J Clin Oncol; 2016 Jun; 34(18):2172-81. PubMed ID: 27114602
[TBL] [Abstract][Full Text] [Related]
55. Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: 11 year follow-up of a prospective observational study.
Villani A; Shore A; Wasserman JD; Stephens D; Kim RH; Druker H; Gallinger B; Naumer A; Kohlmann W; Novokmet A; Tabori U; Tijerin M; Greer ML; Finlay JL; Schiffman JD; Malkin D
Lancet Oncol; 2016 Sep; 17(9):1295-305. PubMed ID: 27501770
[TBL] [Abstract][Full Text] [Related]
56. The TP53 mutation, R337H, is associated with Li-Fraumeni and Li-Fraumeni-like syndromes in Brazilian families.
Achatz MI; Olivier M; Le Calvez F; Martel-Planche G; Lopes A; Rossi BM; Ashton-Prolla P; Giugliani R; Palmero EI; Vargas FR; Da Rocha JC; Vettore AL; Hainaut P
Cancer Lett; 2007 Jan; 245(1-2):96-102. PubMed ID: 16494995
[TBL] [Abstract][Full Text] [Related]
57. [Genetics of colorectal cancer. I. Non-polyposis and polyposis forms of hereditary colorectal cancer].
Menko FH; Griffioen G; Wijnen JT; Tops CM; Fodde R; Vasen HF
Ned Tijdschr Geneeskd; 1999 Jun; 143(23):1201-6. PubMed ID: 10389534
[TBL] [Abstract][Full Text] [Related]
58. [New knowledge of Li-Fraumeni syndrome].
Funato M; Kondo N
Gan To Kagaku Ryoho; 2013 Feb; 40(2):148-53. PubMed ID: 23411951
[TBL] [Abstract][Full Text] [Related]
59. Next generation sequencing is informing phenotype: a TP53 example.
O'Shea R; Clarke R; Berkley E; Giffney C; Farrell M; O'Donovan E; Gallagher DJ
Fam Cancer; 2018 Jan; 17(1):123-128. PubMed ID: 28509937
[TBL] [Abstract][Full Text] [Related]
60. Attitudes of von Hippel-Lindau disease patients towards presymptomatic genetic diagnosis in children and prenatal diagnosis.
Levy M; Richard S
J Med Genet; 2000 Jun; 37(6):476-8. PubMed ID: 10928862
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]